Aspirin and cancer: What have shown the studies

People who consume aspirin on a systematic basis, exhibit a significantly reduced risk of developing cancer, especially in the gastrointestinal tract and the gut, according to a new study by american scientists presented Wednesday.
The results of this study were published in the american journal “Journal of the American Medical Association (JAMA) Oncology” and recommend that aspirin should accompany, not replace, already proven methods that predict the emergence of cancer, such as colonoscopy.
“Now we can recommend the people to consider and the possibility of consumption of aspirin to reduce the risk of developing colon cancer, especially for those who consume already systematically and for other reasons, such as heart diseases,” said the head of research Andrew Chan of Massachusetts General Hospital.
“Our findings show that the use of aspirin can result in significantly reduced rates of cancers of the bowel, in addition to those provided through the exams”, added he.
The researchers studied data of 32 years from approximately 136.000 nurses and health professionals. Those who took either regular aspirin, or the most light at least two times per week showed a 3% lower risk of any cancer. The benefit from the use of aspirin occurs after at least five years of regular use, highlight scholars and in the case of cancer of the bowel or the gastric tube, the chances of non-occurrence are increased to 19% and 15%, respectively.